A carregar...
Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?
PURPOSE: The Food and Drug Administration Expanded Access (EA) program and “Right‐to‐Try” legislation aim to provide seriously ill patients who have no other comparable treatment options to gain access to investigational drugs and biological agents. Physicians and institutions need to understand the...
Na minha lista:
| Publicado no: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4503515/ https://ncbi.nlm.nih.gov/pubmed/25588691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12255 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|